| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 01/28/2015 | EP2827900A1 Treatment of brain cancer |
| 01/28/2015 | EP2827880A1 A mixture of polar glycolipids for use in the treatment of pain and copd |
| 01/28/2015 | EP2827877A1 Uses of antagonists of hyaluronan signaling |
| 01/28/2015 | EP2827876A1 Pharmaceutical combinations comprising a thionucleotide analog |
| 01/28/2015 | EP2827875A1 Substituted nucleosides, nucleotides and analogs thereof |
| 01/28/2015 | EP2827874A1 Pharmaceutical composition comprising empagliflozin and antiobesity drug |
| 01/28/2015 | EP2827873A1 Method for treating gynecological diseases |
| 01/28/2015 | EP2827872A1 Combination of a 6-oxo-1,6-dihydro-pyridazine derivative having anti-cancer activity with other anti-tumor compounds |
| 01/28/2015 | EP2827871A1 Use of (rs)-s-cyclopropyl-s-(4-{[4-{[1r, 2r)-2-hydroxy-1-methylpropyl]oxy}-5-(trifluoromethyl)pyrimidin-2-yl]amino}phenyl)sulfoximide for treating specific tumours |
| 01/28/2015 | EP2827870A1 Chemical compounds |
| 01/28/2015 | EP2827869A2 Compositions and methods to improve the therapeutic benefit of indirubin and analogs thereof, including meisoindigo |
| 01/28/2015 | EP2827868A1 Pharmaaceutical compositions comprising fatty acid esters |
| 01/28/2015 | EP2827867A1 Pharmaceutical compositions comprising glycerol esters |
| 01/28/2015 | EP2827866A1 Pharmaceutical compositions comprising benzyl alcohol |
| 01/28/2015 | EP2827865A1 Treatment of microbial infections |
| 01/28/2015 | EP2827864A1 Inhibition of mcl-1 and/or bfl-1/a1 |
| 01/28/2015 | EP2827863A1 Method of treating bendamustine-responsive conditions in patients requiring reduced volumes for administration |
| 01/28/2015 | EP2827862A1 Formulations of bendamustine |
| 01/28/2015 | EP2827861A1 Composition and methods for cell modulation |
| 01/28/2015 | EP2827860A1 Use of a pyrazole derivative in the treatment of acute exacerbations of chronic obstructive pulmonary disease |
| 01/28/2015 | EP2827859A1 Combination therapy (vemrufenib and a mdm2 inhibitor) for the treatment proliferative disorders |
| 01/28/2015 | EP2827858A1 Method for administration of an anti tumor agent |
| 01/28/2015 | EP2827857A1 Spirocyclic dihydro-thiazine and dihydro-oxazine bace inhibitors, and compositions and uses thereof |
| 01/28/2015 | EP2827856A1 Compounds and compositions for the treatment of muscular disorders |
| 01/28/2015 | EP2827855A1 Methods of treating cancer using aurora kinase inhibitors |
| 01/28/2015 | EP2827854A1 Use of amphoteric surfactants for the prevention and treatment of pathogenic vaginal biofilms in vaginal infections |
| 01/28/2015 | EP2827853A1 Compositions and methods for oral delivery of encapsulated diethylenetriaminepentaacetate particles |
| 01/28/2015 | EP2827852A1 Extended-release formulation for reducing the frequency of urination and method of use thereof |
| 01/28/2015 | EP2827851A1 Extended-release formulation for reducing the frequency of urination and method of use thereof |
| 01/28/2015 | EP2827850A1 Beta-hydroxy-beta-methylbutyric acid for improving glucose tolerance |
| 01/28/2015 | EP2827849A1 Treatment of pulmonary hypertension with leukotriene inhibitors |
| 01/28/2015 | EP2827848A1 Stabilized pharmaceutical compositions comprising rasagiline salts |
| 01/28/2015 | EP2827847A1 Topically administered strontium-containing complexes for treating pain, pruritis and inflammation |
| 01/28/2015 | EP2827846A1 Treatment of schizophrenia using beta-caryophyllene and cb2 receptor agonists |
| 01/28/2015 | EP2827844A1 Pharmaceutical formulation comprising bendamustine |
| 01/28/2015 | EP2827843A1 Method for producing enteric alginate microcapsules via ionic gelation containing diclofenac or one of the salts thereof and multiparticled pharmaceutical composition containing them |
| 01/28/2015 | EP2827837A2 Exopolysaccharide for the treatment and/or care of the skin, mucous membranes and/or nails |
| 01/28/2015 | EP2827724A1 Fermented infant formula with non digestible oligosaccharides |
| 01/28/2015 | EP2827711A1 APP SPECIFIC BACE INHIBITORS (ASBIs) AND USES THEREOF |
| 01/28/2015 | CN104321333A 硫代氨基磷酸酯核苷酸前药的固体形式 Solid form thio phosphoramidates nucleotide prodrug |
| 01/28/2015 | CN104321326A 氨基取代的咪唑并哒嗪 Amino substituted imidazopyridazine |
| 01/28/2015 | CN104321325A 吡咯并吡咯烷酮化合物 Pyrrolo pyrrolidone compound |
| 01/28/2015 | CN104321324A 取代的稠合咪唑类和吡唑类化合物及其用途 Substituted fused imidazole and pyrazole compounds and their use |
| 01/28/2015 | CN104321323A 碳环核苷及其医药用途和组合物 Carbocyclic nucleosides and their medicinal uses and compositions |
| 01/28/2015 | CN104321322A 作为c-met蛋白激酶调节剂的新型3,5-二取代-3h-咪唑并[4,5-b]吡啶和3,5-二取代-3h-[1,2,3]三唑并[4,5-b]吡啶化合物 As the c-met protein kinase modulators -3h- novel 3,5-disubstituted imidazo [4,5-b] pyridine and 3,5-disubstituted -3h- [1,2,3] triazolo [ 4,5-b] pyridine compound |
| 01/28/2015 | CN104321321A 新型二环噻唑类化合物 Novel bicyclic thiazoles |
| 01/28/2015 | CN104321319A 新的茚满基氧基二氢苯并呋喃乙酸衍生物及其用作gpr40 受体激动剂的用途 New indan-yloxy dihydrobenzofuran acid derivatives and their use as agonists of use gpr40 |
| 01/28/2015 | CN104321318A 4-烷酰基氨基-3-吡唑啉酮衍生物 4- alkanoylamino -3- pyrazolone derivative |
| 01/28/2015 | CN104321316A 3'平伏氟取代的神经氨酸酶抑制剂化合物、组合物及其用作抗病毒剂的方法 Neuraminidase inhibitor compound 3 'equatorial fluorine-substituted, compositions and methods as antiviral agents |
| 01/28/2015 | CN104321313A 为用于治疗良性前列腺增生的α1A、α1D肾上腺素能受体和5-HT1A受体的拮抗剂的N-苯基哌嗪衍生物,包含所述N-苯基哌嗪衍生物的药物组合物 For the treatment of benign prostatic hyperplasia α1A, α1D adrenergic receptors and 5-HT1A receptor antagonist N- phenylpiperazine derivative, comprising the N- phenylpiperazine derivative pharmaceutical compositions |
| 01/28/2015 | CN104321312A 氯化n-甲基-4-苄基氨基甲酰基吡啶*及其制备方法 Chloride, n- methyl-4-benzylamino-formylpyridine * and preparation method |
| 01/28/2015 | CN104321309A 作为alx受体激动剂的经氟化桥联的螺[2.4]庚烷衍生物 As alx receptor agonists Lo fluorinated bridged [2.4] heptane derivatives |
| 01/28/2015 | CN104321300A 脂肪酸的2-羟基衍生物的对映体 Enantiomer of 2-hydroxy fatty acid derivative |
| 01/28/2015 | CN104321083A 用于成像和治疗的亚乙双半胱氨酸-糖缀合物的有效合成 For imaging and therapy of ethylene bis-cysteine - efficient synthesis of glycoconjugate |
| 01/28/2015 | CN104321074A 生长抑素类似物与11β-羟化酶抑制剂的组合 Somatostatin analogues in combination with 11β- hydroxylase inhibitors |
| 01/28/2015 | CN104321070A Alk1拮抗剂及其在治疗肾细胞癌中的用途 Alk1 antagonists and their use in the treatment of renal cell carcinoma |
| 01/28/2015 | CN104321066A 用于治疗疼痛和copd的极性糖脂的混合物 A mixture of pain and treatment for copd polar glycolipids |
| 01/28/2015 | CN104321064A 软骨素用于医学 Chondroitin for medical |
| 01/28/2015 | CN104321063A 壳聚糖聚合物用于治疗和预防冠状病毒引起的感染的用途 Chitosan polymers for use in the treatment and prevention of coronavirus infection caused |
| 01/28/2015 | CN104321062A 干细胞微粒 Stem cell particles |
| 01/28/2015 | CN104321061A 施用依立托伦或其药学上可接受的盐以治疗正粘病毒感染 Administered in accordance with the legislation in Torun, or a pharmaceutically acceptable salt thereof to treat infections orthomyxovirus |
| 01/28/2015 | CN104321060A α-氨基硼酸衍生物,选择性免疫蛋白酶体抑制剂 α- amino boronic acid derivative, a selective immune proteasome inhibitor |
| 01/28/2015 | CN104321059A 食欲素受体拮抗剂的固体剂量制剂 Orexin receptor antagonists solid dosage formulation |
| 01/28/2015 | CN104321058A 用于治疗低磷血性疾病的fgfr抑制剂 For the treatment of hemorrhagic disease fgfr phosphorus inhibitors |
| 01/28/2015 | CN104321057A 用于治疗帕金森病的方法 Method for the treatment of Parkinson's disease |
| 01/28/2015 | CN104321056A 用于缓解尿频的延长释放制剂及其使用方法 Used to relieve urinary prolonged release formulations and methods of use |
| 01/28/2015 | CN104321055A 游离酸形式的ω-3多不饱和脂肪酸的富含dpa组合物 The free acid form of ω-3 polyunsaturated fatty acid-rich compositions dpa |
| 01/28/2015 | CN104321054A 睡眠质量改善剂 Sleep quality improving agent |
| 01/28/2015 | CN104321053A ω-3脂肪酸酯组合物 ω-3 fatty acid ester composition |
| 01/28/2015 | CN104320978A β-葡聚糖与阿拉伯糖基木聚糖的缔合物 β- glucan and xylan arabinopyranosyl association complex |
| 01/28/2015 | CN104320971A 用于预防和治疗创伤的组合物和方法 Compositions and methods for the prevention and treatment of wounds |
| 01/28/2015 | CN104313043A 一种骨质疏松斑马鱼模型的构建方法及其应用 A method of constructing osteoporosis zebrafish model and its application |
| 01/28/2015 | CN104311870A 一种医用止血多聚糖淀粉微球及其制备方法 A medical hemostatic polysaccharide starch microspheres and its preparation method |
| 01/28/2015 | CN104311831A A54-葡聚糖-聚乳酸-羟基乙酸共聚物及制备与应用 A54- dextran - polylactic acid - glycolic acid copolymer and the preparation and application |
| 01/28/2015 | CN104311822A 一种卡宾-重氮化合物-烯醛的三元共聚物及其作为双向转换荧光材料和抗癌药物的用途 One kind of carbene - diazo - enal terpolymers and as a two-way conversion fluorescent material and the use of anti-cancer drugs |
| 01/28/2015 | CN104311821A 一种具有双重响应性聚合物载药纳米胶束的制备 A method for preparing a double-responsive polymer drug loaded micelles have |
| 01/28/2015 | CN104311696A 一种低聚海藻酸钠制备在药品保健品及食盐制品中的应用 Preparation of an oligomeric alginate applications in the pharmaceutical and health care products in the salt |
| 01/28/2015 | CN104311683A 高取代度瓜尔豆胶磷酸酯的合成及应用 Synthesis and Application of high degree of substitution of guar gum phosphate |
| 01/28/2015 | CN104311622A 一种积雪草酸酰胺类衍生物 One kind of asiatic acid amide derivatives |
| 01/28/2015 | CN104311604A 一种金属钴配合物及其制备方法和应用 Metal cobalt complex and its preparation method and application |
| 01/28/2015 | CN104311600A -苯基氨基硫脲芳基钌配合物及其制备方法和用途 - Phenyl thiosemicarbazide aryl ruthenium complexes and their preparation and use |
| 01/28/2015 | CN104311575A 含有稠环的吡唑并哌啶酮类化合物及其组合物及用途 Pyrazole-containing fused ring and piperidine ketone compounds, compositions and uses |
| 01/28/2015 | CN104311574A 含有噻唑的吡唑并哌啶酮类化合物及其组合物及用途 Pyrazole and thiazole-containing piperidine ketone compounds and compositions thereof and uses |
| 01/28/2015 | CN104311573A 抑制btk和/或jak3激酶活性的化合物 Inhibition btk and / or kinase activity of a compound jak3 |
| 01/28/2015 | CN104311570A 一种含有香豆素结构的木脂素类化合物及其制备方法与应用 Lignan compound and its preparation method and application structure containing coumarin |
| 01/28/2015 | CN104311562A 用于治疗瘤形成、炎性疾病和其他失调的组合物和方法 For the treatment of neoplasia, inflammatory diseases and other disorders of the compositions and methods |
| 01/28/2015 | CN104311558A 含有环己烷取代基的吡唑并哌啶酮类化合物及其组合物及用途 Cyclohexane containing substituent pyrazolo piperidine ketone compounds and compositions and uses |
| 01/28/2015 | CN104311557A 含有二酮取代基的吡唑并哌啶酮类化合物及其组合物及用途 Dione containing substituent pyrazolo piperidine ketone compounds, compositions and uses |
| 01/28/2015 | CN104311556A 含有环氧烷基取代基的吡唑并哌啶酮类化合物及其组合物及用途 Pyrazole containing an epoxy group and an alkyl-substituted piperidine ketone compounds, compositions and uses |
| 01/28/2015 | CN104311555A 吡唑并哌啶酮类化合物及其组合物及用途 Pyrazolo piperidine ketone compounds, compositions and uses |
| 01/28/2015 | CN104311552A 囊泡单胺转运体2 的苯并喹啉抑制剂 Vesicular monoamine transporter 2 inhibitors benzoquinoline |
| 01/28/2015 | CN104311541A 含取代的甲酮的吡唑类化合物及其组合物及用途 Methanone containing substituted pyrazole compounds and compositions and uses |
| 01/28/2015 | CN104311539A 一种吖啶酰腙类衍生物及其制备方法和用途 One kind acylhydrazone acridine derivatives and preparation method and use |
| 01/28/2015 | CN104311537A 含有嘧啶酮乙酰基取代基吡唑类化合物及其组合物及用途 Containing pyrimidinone acetyl substituent pyrazole compounds and compositions and uses |
| 01/28/2015 | CN104311526A 海洋真菌来源的联萘类衍生物及其制备方法与在抗结核中的应用 Marine fungal origin binaphthyl derivatives and preparation method and application of anti-TB |
| 01/28/2015 | CN104311525A 海洋真菌来源的Azaphilone类化合物在制备抗结核药物中的应用 Azaphilone class of compounds derived from marine fungus used in the preparation of anti-TB drugs |
| 01/28/2015 | CN104311519A 具有胃黏膜损伤保护作用的功能性食品因子制备及其应用 Prepare a gastric mucosal injury in its application of functional food factor |
| 01/28/2015 | CN104311517A 多取代菲环类他汀内酯脱水化合物及其用途 Poly-substituted phenanthrene ring lactone class of statin compounds and their uses dehydration |
| 01/28/2015 | CN104311509A 截短侧耳素类衍生物及其制备方法、应用 Pleuromutilins derivatives and preparation methods, application |
| 01/28/2015 | CN104311494A 间-(4-吗啉基-2-喹唑啉基)苯甲酰胺类化合物及其合成方法和应用 Room - (4-morpholino-2-quinazolinyl) benzamide compounds and synthetic methods and applications |